• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VEGF-A 将血管淋巴样增生伴嗜酸性粒细胞增多症 (ALHE) 与 THSD7A 膜性肾病联系起来:2 例报告。

VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.

机构信息

Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.

Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.

出版信息

Am J Kidney Dis. 2019 Jun;73(6):880-885. doi: 10.1053/j.ajkd.2018.10.009. Epub 2018 Dec 13.

DOI:10.1053/j.ajkd.2018.10.009
PMID:30554801
Abstract

Autoantibodies against thrombospondin type 1 domain-containing 7A (THSD7A) cause membranous nephropathy (MN); however, the mechanisms involved in THSD7A expression and immunization are uncertain. We present 2 cases of THSD7A-associated MN accompanied by angiolymphoid hyperplasia with eosinophilia (ALHE), a benign tumor characterized by proliferation of plump endothelial cells. Prednisolone therapy, but not surgical resection of ALHE tumors, successfully suppressed eosinophilia and proteinuria in both cases. Because ALHE is characterized by the proliferation of plump endothelial cells, we focused on the roles of vascular endothelial growth factor A (VEGF-A) in MN pathogenesis. We found that plump endothelial cells in ALHE modestly expressed THSD7A in both cases. We also found that eosinophils in ALHE expressed VEGF-A, which upregulated THSD7A expression, especially under T-helper type 2-prone conditions in cultured endothelial cells. Furthermore, double-positive cells for THSD7A and CD83 surrounded the proliferated small vessels. Our results suggest that VEGF-A-induced THSD7A expression outside the kidney may be important for MN pathogenesis.

摘要

自身抗体针对血栓反应蛋白 1 型结构域包含 7A 型(THSD7A)可导致膜性肾病(MN);然而,THSD7A 表达和免疫的机制尚不确定。我们报告了 2 例伴有血管淋巴样增生伴嗜酸性粒细胞增多症(ALHE)的 THSD7A 相关 MN,ALHE 是一种良性肿瘤,其特征是丰满的内皮细胞增殖。泼尼松龙治疗,而不是手术切除 ALHE 肿瘤,成功地抑制了两例中的嗜酸性粒细胞增多和蛋白尿。由于 ALHE 的特征是丰满的内皮细胞增殖,我们专注于血管内皮生长因子 A(VEGF-A)在 MN 发病机制中的作用。我们发现,在两种情况下,ALHE 中的丰满内皮细胞适度表达 THSD7A。我们还发现,ALHE 中的嗜酸性粒细胞表达 VEGF-A,这在上皮细胞培养中尤其在辅助性 T 细胞 2 倾向条件下上调了 THSD7A 的表达。此外,THSD7A 和 CD83 双阳性细胞环绕增殖的小血管。我们的结果表明,VEGF-A 诱导的肾外 THSD7A 表达可能对 MN 发病机制很重要。

相似文献

1
VEGF-A Links Angiolymphoid Hyperplasia With Eosinophilia (ALHE) to THSD7A Membranous Nephropathy: A Report of 2 Cases.VEGF-A 将血管淋巴样增生伴嗜酸性粒细胞增多症 (ALHE) 与 THSD7A 膜性肾病联系起来:2 例报告。
Am J Kidney Dis. 2019 Jun;73(6):880-885. doi: 10.1053/j.ajkd.2018.10.009. Epub 2018 Dec 13.
2
Treatment of Membranous Nephropathy in Patients With THSD7A Antibodies Using Immunoadsorption.免疫吸附治疗 THSD7A 抗体相关膜性肾病。
Am J Kidney Dis. 2019 Dec;74(6):849-852. doi: 10.1053/j.ajkd.2019.05.021. Epub 2019 Aug 23.
3
Observation of Angiolymphoid Hyperplasia with Eosinophilia (ALHE) at Three Arterial Sites and Its Association with Membranous Nephropathy.三个动脉部位嗜酸性粒细胞增多性血管淋巴样增生症(ALHE)的观察及其与膜性肾病的关联
Intern Med. 2015;54(15):1933-9. doi: 10.2169/internalmedicine.54.4031. Epub 2015 Aug 1.
4
Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report.直肠癌切除术后血栓反应蛋白样蛋白 7A 相关膜性肾病:一例报告。
BMC Nephrol. 2019 Feb 6;20(1):43. doi: 10.1186/s12882-019-1236-y.
5
Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.一名成年女性伴嗜酸性粒细胞增多的血栓反应蛋白型 1 结构域包含 7A(THSD7A)相关膜性肾病。
CEN Case Rep. 2020 Feb;9(1):65-73. doi: 10.1007/s13730-019-00430-3. Epub 2019 Nov 8.
6
Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.抗含血小板反应蛋白1结构域7A自身抗体可诱发膜性肾病。
J Clin Invest. 2016 Jul 1;126(7):2519-32. doi: 10.1172/JCI85265. Epub 2016 May 23.
7
Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.新型 ELISA 法检测膜性肾病中血栓素 A2 型 1 结构域包含蛋白 7A 自身抗体。
Kidney Int. 2019 Mar;95(3):666-679. doi: 10.1016/j.kint.2018.10.024.
8
Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.血栓反应蛋白 1 型结构域包含蛋白 7A 相关膜性肾病的临床病理特征。
Virchows Arch. 2019 Jun;474(6):735-743. doi: 10.1007/s00428-019-02558-0. Epub 2019 Mar 14.
9
An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy.一种间接免疫荧光法有助于检测膜性肾病中含血小板反应蛋白1结构域7A特异性抗体。
J Am Soc Nephrol. 2017 Feb;28(2):520-531. doi: 10.1681/ASN.2016010050. Epub 2016 Jul 19.
10
A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy.含1型血小板反应蛋白结构域7A相关膜性肾病的异源模型
J Am Soc Nephrol. 2017 Nov;28(11):3262-3277. doi: 10.1681/ASN.2017010030. Epub 2017 Aug 16.

引用本文的文献

1
THSD7A as a Promising Biomarker for Membranous Nephrosis.THSD7A 作为膜性肾病有前途的生物标志物。
Mol Biotechnol. 2024 Nov;66(11):3117-3135. doi: 10.1007/s12033-023-00934-5. Epub 2023 Oct 26.
2
VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway.VEGFA 通过 PI3K/AKT 信号通路促进 PLA2R 相关特发性膜性肾病的血管生成发生。
BMC Nephrol. 2022 Sep 16;23(1):313. doi: 10.1186/s12882-022-02936-y.
3
The Role of Anti-PLAR and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice.
抗 PLAR 和抗 THSD7A 抗体在原发性膜性肾病发病机制和诊断中的作用:临床实践的最新知识综述。
Int J Environ Res Public Health. 2022 Apr 27;19(9):5301. doi: 10.3390/ijerph19095301.
4
Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.复发性膜性肾病,病因可能改变:一例报告。
BMC Nephrol. 2021 Jul 6;22(1):253. doi: 10.1186/s12882-021-02457-0.
5
Eosinophilic interstitial nephritis and cardiac insufficiency in Kimura's disease: a case report.Kimura 病致嗜酸性粒细胞性间质性肾炎和心功能不全 1 例报告
BMC Nephrol. 2021 Jun 30;22(1):241. doi: 10.1186/s12882-021-02454-3.
6
Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy.特发性血栓性血小板减少性紫癜相关性膜性肾病自发缓解。
Intern Med. 2021 Oct 1;60(19):3125-3128. doi: 10.2169/internalmedicine.6413-20. Epub 2021 Apr 12.
7
Perspectives in membranous nephropathy.膜性肾病的观点。
Cell Tissue Res. 2021 Aug;385(2):405-422. doi: 10.1007/s00441-021-03429-4. Epub 2021 Apr 6.
8
Mechanisms of Primary Membranous Nephropathy.原发性膜性肾病的发病机制。
Biomolecules. 2021 Mar 30;11(4):513. doi: 10.3390/biom11040513.
9
Single cell RNA sequencing uncovers cellular developmental sequences and novel potential intercellular communications in embryonic kidney.单细胞 RNA 测序揭示了胚胎肾中细胞发育序列和新的潜在细胞间通讯。
Sci Rep. 2021 Jan 8;11(1):73. doi: 10.1038/s41598-020-80154-y.
10
Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity.特发性膜性肾病:由肾外免疫活性引起的肾小球病理形态。
Front Immunol. 2020 Sep 16;11:1846. doi: 10.3389/fimmu.2020.01846. eCollection 2020.